Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

Danish drugmaker Novo Nordisk presented its annual report in Bagsvaerd, Denmark, showcasing flags with the company’s logos, including those of its popular diabetes and weight-loss treatments Ozempic and Wegovy. The event, held on February 5, 2025, featured images of the flags as Novo Nordisk highlighted its achievements and financial performance. The presentation emphasized the company’s commitment to innovation and success in the pharmaceutical industry.

Full Article